Oncogenic HPV infection interrupts the expression of tumor-suppressive miR-34a through viral oncoprotein E6

RNA

Volumn 15, Issue 4, 2009, Pages 637-647

  Wang, Xiaohong ^a   Wang, Hsu Kun ^b   Mccoy, J Philip ^c   Banerjee, Nilam S ^b   Rader, Janet S ^d   Broker, Thomas R ^b   Meyers, Craig ^e   Chow, Louise T ^b   Zheng, Zhi Ming ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

E6; Human papillomavirus; Mir 34a; Oncoprotein; P53

Indexed keywords

MICRORNA; PROTEIN E6; PROTEIN P53;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL GROWTH; GENE EXPRESSION; HUMAN; HUMAN CELL; KERATINOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UTERINE CERVIX CANCER; VERRUCA VULGARIS;

ADULT; CELL LINE, TUMOR; DNA-BINDING PROTEINS; FEMALE; GENE KNOCKDOWN TECHNIQUES; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; MICRORNAS; MIDDLE AGED; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS INFECTIONS; REPRESSOR PROTEINS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPES;

EID: 62549156668     PISSN: 13558382     EISSN: 14699001     Source Type: Journal    
DOI: 10.1261/rna.1442309     Document Type: Article

References (58)

1. Banerjee, N.S., Chow, L.T., and Broker, T.R. 2005. Retrovims-mediated gene transfer to analyze HPV gene regulation and protein functions in organotypic "raft" cultures. Methods Mol. Med. 119: 187-202.
2. Bommer, G.T., Gerin, I., Feng, Y., Kaczorowski, A.J., Kuick, R., Love, R.E., Zhai, Y., Giordano, T.J., Qin, Z.S., Moore, B.B., et al. 2007. p53-mediated activation of miRNA34 candidate tumor- suppressor genes. Curr. Biol. 17: 1298-1307.
3. Brennecke, J., Stark, A., Russell, R.B., and Cohen, S.M. 2005. Principles of microRNA-target recognition. PLoS Biol. 3: e85. doi: 10.1371/journal.pbio.0030085.
4. Cai, X., Lu, 8., Zhang, Z., Gonzalez, CM., Damania, B., and Cullen, B.R. 2005. Kaposi's sarcoma-associated herpesvirus expresses an array of viral microRNAs in latently infected cells. Proc. Natl. Acad. Sci. 102: 5570-5575.
5. Calin, G.A. and Croce, CM. 2006. MicroRNA signatures in human cancers. Nat. Rev. Cancer 6: 857-866.
6. Chang, T.C., Wentzel, E.A., Kent, O.A., Ramachandran, K., Mullendore, M., Lee, K.H., Feldmann, G., Yamakuchi, M., Ferlito, M., Lowenstein, C.J., et al. 2007. Transactivation of miR- 34a by p53 broadly influences gene expression and promotes apoptosis. Mol. Cell 26: 745-752.
7. Chellappan, S., Kraus, V.B., Kroger, B., Munger, K., Howley, P.M., Phelps, W.C., and Nevins, J.R. 1992. Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product. Proc. Natl. Acad. Sci. 89: 4549-4553.
8. Cheng, S., Schmidt-Grimminger, D.C., Murant, T., Broker, T.R., and Chow, L.T. 1995. Differentiation-dependent up-regulation of the human papillomavirus E7 gene reactivates cellular DNA replication in suprabasal differentiated keratinocytes. Genes & Dev. 9: 2335-2349.
9. Cobrinik, D. 2005. Pocket proteins and cell cycle control. Oncogene 24: 2796-2809.
10. Crook, T., Wrede, D., and Vousden, K.H. 1991. p53 point mutation in HPV negative human cervical carcinoma cell lines. Oncogene 6: 873-875.
11. Dollard, S.C., Wilson, J.L., Demeter, L.M., Bonnez, W., Reichman, R.C., Broker, T.R., and Chow, L.T. 1992. Production of human papillomavirus and modulation of the infectious program in epithelial raft cultures. Genes & Dev. 6: 1131-1142.
12. Farh, K.K., Crimson, A., Jan, C., Lewis, B.P., Johnston, W.K., Lim, L.P., Burge, C.B., and Bartel, D.P. 2005. The widespread impact of mammalian microRNAs on mRNA repression and evolution. Science 310: 1817-1821.
13. Fogal, V., Hsieh, J.K., Royer, C., Zhong, 8., and Lu, X. 2005. Cell cycle-dependent nuclear retention of p53 by E2F1 requires phosphorylation of p53 at Ser315. EMBO J. 24: 2768-2782.
14. Genovese, N.J., Banerjee, N.S., Broker, T.R., and Chow, L.T. 2008. Casein kinase II motif-dependent phosphorylation of the human papillomavirus E7 protein promotes p130 degradation and S-phase induction in differentiated human keratinocytes. J. Virol. 82: 4862-4873.
15. Gonzalez, S.L., Stremlau, M., He, X., Basile, J.R., and Munger, K. 2001. Degradation of the retinoblastoma tumor suppressor by the human papillomavirus type 16 E7 oncoprotein is important for functional inactivation and is separable from proteasomal degradation of E7. J. Virol. 75: 7583-7591.
16. Grimson, A., Farh, K.K., Johnston, W.K., Garrett-Engele, P., Lim, L.P., and Bartel, D.P. 2007. MicroRNA targeting specificity in mammals: Determinants beyond seed pairing. Mol. Cell 27: 91- 105.
17. Halazonetis, T.D., Gorgoulis, V.G., and Bartek, J. 2008. An oncogene- induced DNA damage model for cancer development. Science 319: 1352-1355.
18. He, L., He, X., Lim, L.P., de Stanchina, E., Xuan, Z., Liang, Y., Xue, W., Zender, L., Magnus, J., Ridzon, D., et al. 2007. A microRNA component of the p53 tumour suppressor network. Nature 447: 1130-1134.
19. Hwang, H.W., Wentzel, E.A., and Mendell, J.T. 2007. A hexanucleotide element directs microRNA nuclear import. Science 315: 97-100.
20. Jones, D.L. and Munger, K. 1997. Analysis of the p53-mediated G, growth arrest pathway in cells expressing the human papillomavirus type 16 E7 oncoprotein. J. Virol. 71: 2905-2912.
21. Landgraf, P., Rusu, M., Sheridan, R., Sewer, A., Iovino, N., Aravin, A., Pfeffer, S., Rice, A., Kamphorst, A.O., Landthaler, M., et al. 2007. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129: 1401-1414.
22. Lehman, T.A., Modali, R., Boukamp, P., Stanek, J., Bennett, W.P., Welsh, J.A., Metcalf, R.A., Stampfer, M.R., Fusenig, N., Rogan, E.M., et al. 1993. p53 mutations in human immortalized epithelial cell lines. Carcinogenesis 14: 833-839.
23. Lewis, B.P., Burge, C.B., and Bartel, D.P. 2005. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20.
24. Lodygin, D., Tarasov, V., Epanchintsev, A., Berking, C., Knyazeva, T., Korner, H., Knyazev, P., Diebold, J., and Hermeking, H. 2008. Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer. Cell Cycle 7: 2591-2600.
25. Longuet, M., Beaudenon, 8., and Orth, G. 1996. Two novel genital human papillomavirus (HPV) types, HPV68 and HPV70, related to the potentially oncogenic HPV39. J. Clin. Microbiol. 34: 738- 744.
26. Lytle, J.R., Yario, T.A., and Steitz, J.A. 2007. Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5′ UTR as in the 3′ UTR. Proc. Natl. Acad. Sci. 104: 9667-9672.
27. Maroney, P.A., Chamnongpol, S., Souret, F., and Nilsen, T.W. 2007. A rapid, quantitative assay for direct detection of microRNAs and other small RNAs using splinted ligation. RNA 13: 930-936.
28. McLaughlin-Drubin, M.E. and Meyers, C. 2005. Propagation of infectious, high-risk HPV in organotypic "raft" culture. Methods Mol. Med. 119: 171-186.
29. Meyers, C., Frattini, M.G., Hudson, J.B., and Laimins, L.A. 1992. Biosynthesis of human papillomavirus from a continuous cell line upon epithelial differentiation. Science 257: 971-973.
30. Mirza, A., Wu, Q., Wang, L., McClanahan, T., Bishop, W.R., Gheyas, F., Ding, W., Hutchins, B., Hockenberry, T., Kirschmeier, P., et al. 2003. Global transcriptional program of p53 target genes during the process of apoptosis and cell cycle progression. Oncogene 22: 3645-3654.
31. Munger, K., Baldwin, A., Edwards, K.M., Hayakawa, H., Nguyen, C.L., Owens, M., Grace, M., and Huh, K. 2004. Mechanisms of human papillomavirus- induced oncogenesis. J. Virol. 78: 11451-11460.
32. Muñoz, N., Bosch, F.X., de Sanjosé, S., Herrero, R., Castellsagué, X., Shah, K.V., Snijders, P.J., and Meijer, C.J.; International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. 2003. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med. 348: 518-527.
33. Nielsen, C.B., Shomron, N., Sandberg, R., Hornstein, E., Kitzman, J., and Burge, C.B. 2007. Determinants of targeting by endogenous and exogenous microRNAs and siRNAs. RNA 13: 1894-1910.
34. cip1 degradation in differentiated keratinocytes is abrogated by co- stabilization with cyclin E induced by human papillomavirus E7. J. Virol. 75: 6121-6134.
35. Cip-1/WAFI/MDA6.J. Biol Chem. 275: 18-28.
36. Pfeffer, S., Zavolan, M., Grasser, F.A., Chien, M., Russo, J.J., Ju, J., John, B., Enright, A.J., Marks, D., Sander, C., et al. 2004. Identification of virus-encoded microRNAs. Science 304: 734-736.
37. Pfeffer, S., Sewer, A., Lagos-Quintana, M., Sheridan, R., Sander, C., Grasser, F.A., van Dyk, L.F., Ho, C.K., Shuman, S., Chien, M., et al. 2005. Identification of microRNAs of the herpesvirus family. Nat. Methods 2: 269-276.
38. Raver-Shapira, N., Marciano, E., Meiri, E., Spector, Y., Rosenfeld, N., Moskovits, N., Bentwich, Z., and Oren, M. 2007. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol. Cell 26: 731-743.
39. Samols, M.A., Hu, J., Skalsky, R.L., and Renne, R. 2005. Cloning and identification of a microRNA cluster within the latency-associated region of Kaposi's sarcoma-associated herpesvirus. J. Virol. 79: 9301-9305.
40. Scheffner, M., Werness, B.A., Huibregtse, J.M., Levine, A.J., and Howley, P.M. 1990. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63: 1129-1136.
41. Scheffner, M., Munger, K., Byrne, J.C., and Howley, P.M. 1991. The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc. Natl. Acad. Sci. 88: 5523-5527.
42. 1 arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein. Proc. Natl. Acad. Sci. 91: 5320-5324.
43. Stanley, M.A., Browne, H.M., Appleby, M., and Minson, A.C. 1989. Properties of a nontumorigenic human cervical keratinocyte cell line. Int. J. Cancer 43: 672-676.
44. Tang, S., Tao, M., McCoy, J.P., and Zheng, Z.M. 2006a. Short-term induction and long-term suppression of HPV16 oncogene silencing by RNA interference in cervical cancer cells. Oncogene 25: 2094-2104.
45. Tang, 8., Tao, M., McCoy Jr., J.P., and Zheng, Z.M. 2006b. The E7 oncoprotein is translated from spliced E6*I transcripts in high-risk human papillomavirus type 16- or type 18-positive cervical cancer cell lines via translation reinitiation. J. Virol. 80: 4249-4263.
46. Tang, S., Bertke, A.S., Patel, A., Wang, K., Cohen, J.I., and Krause, P.R. 2008. An acutely and latently expressed herpes simplex virus 2 viral microRNA inhibits expression of ICP34.5, a viral neurovirulence factor. Proc. Natl. Acad. Sci. 105: 10931-10936.
47. Tao, M., Kruhlak, M., Xia, S., Androphy, E., and Zheng, Z.M. 2003. Signals that dictate nuclear localization of human papillomavirus type 16 oncoprotein E6 in living cells. J. Virol 77: 13232- 13247.
48. 1-arrest. Cell Cycle 6: 1586-1593.
49. Tazawa, H., Tsuchiya, N., Izumiya, M., and Nakagama, H. 2007. Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells. Proc. Natl. Acad. Sci. 104: 15472-15477.
50. Umbach, J.L., Kramer, M.F., Jurak, I., Karnowski, H.W., Coen, D.M., and Cullen, B.R. 2008. MicroRNAs expressed by herpes simplex virus 1 during latent infection regulate •viral mRNAs. Nature 454: 780-783.
51. Vousden, K.H. and Lane, D.P. 2007. p53 in health and disease. Nat. Rev. Mol. Cell Biol. 8: 275-283.
52. Wang, X., Tang, S., Le, S.Y., Lu, R., Rader, J.S., Meyers, C., and Zheng, Z.M. 2008. Aberrant expression of oncogenic and tumor- suppressive microRNAs in cervical cancer is required for cancer cell growth. PLoS One 3: e2557. doi: 10.1371/joumal.pone.0002557.
53. Wang, H.-K., Duffy, A., Broker, T.R., and Chow, L.T. 2009. Robust production and passaging of infectious HPV in squamous epithelium of primary human keratinocytes. Genes & Dev. 23: 181-194.
54. Welch, C., Chen, Y., and Stallings, R.L. 2007. MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells. Oncogene 26: 5017-5022.
55. Wilson, J.L., Dollard, S.C., Chow, L.T., and Broker, T.R. 1992. Epithelial-specific gene expression during differentiation of stratified primary human keratinocyte cultures. Cell Growth Differ. 3: 471-483.
56. Yamamoto, H., Soh, J.W., Monden, T., Klein, M.G., Zhang, L.M., Shirin, H., Arber, N., Tomita, N., Schieren, I., Stein, C.A., et al. 1999. Paradoxical increase in retinoblastoma protein in colorectal carcinomas may protect cells from apoptosis. Clin. Cancer Res. 5: 1805-1815.
57. Yi, R., O'Carroll, D., Pasolli, H.A., Zhang, Z., Dietrich, F.S., Tarakhovsky, A., and Fuchs, E. 2006. Morphogenesis in skin is governed by discrete sets of differentially expressed microRNAs. Nat. Genet. 38: 356-362.
58. Zhang, Z., Borecki, I., Nguyen, L., Ma, D., Smith, K., Huettner, P.C., Mutch, D.G., Herzog, T.J., Gibb, R.K., Powell, M.A., et al. 2007. CD83 gene polymorphisms increase susceptibility to human invasive cervical cancer. Cancer Res. 67: 11202-11208.